BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36222552)

  • 1. Psychometric properties of the Croatian version of the Multiple Sclerosis Walking Scale (MSWS-12).
    Jerković A; Nikolić Ivanišević M; Šimić N; Poljičanin A; Đogaš Z; Rogić Vidaković M
    Disabil Rehabil; 2023 Oct; 45(20):3373-3378. PubMed ID: 36222552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties of the Croatian version of the depression, anxiety, and stress scale-21 and multiple sclerosis impact scale-29 in multiple sclerosis patients.
    Rogić Vidaković M; Šimić N; Poljičanin A; Nikolić Ivanišević M; Ana J; Đogaš Z
    Mult Scler Relat Disord; 2021 May; 50():102850. PubMed ID: 33636617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
    Chorschew A; Kesgin F; Bellmann-Strobl J; Flachenecker P; Schiffmann I; Rosenthal F; Althoff P; Drebinger D; Arsenova R; Rasche L; Dorsch EM; Heesen C; Paul F; Stellmann JP; Schmitz-Hübsch T
    Health Qual Life Outcomes; 2023 Oct; 21(1):110. PubMed ID: 37814258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Sclerosis Walking Scale-12, translation, adaptation and validation for the Persian language population.
    Nakhostin Ansari N; Naghdi S; Mohammadi R; Hasson S
    Gait Posture; 2015 Feb; 41(2):420-4. PubMed ID: 25444584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness and clinically meaningful changes for the Persian versions of the multiple sclerosis walking scale-12 and the modified fatigue impact scale following balance and gait rehabilitation in people with multiple sclerosis.
    Monjezi S; Molhemi F; Shaterzadeh Yazdi MJ; Salehi R; Mehravar M; Kashipazha D
    Physiother Theory Pract; 2022 Mar; 38(3):464-470. PubMed ID: 32431220
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychometric properties of the Persian-version of the Activities-specific Balance Confidence scale and Fall Efficacy Scale-International in Iranian patients with multiple sclerosis.
    Monjezi S; Negahban H; Tajali S; Mofateh R; Molhemi F; Mostafaee N
    Physiother Theory Pract; 2021 Aug; 37(8):935-944. PubMed ID: 31455119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis.
    Binshalan T; Buckley E; Nair S; Mcneill A
    Cureus; 2024 Jan; 16(1):e51811. PubMed ID: 38322083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and reliability of the Persian version of the trunk impairment scale in people with multiple sclerosis.
    Korka ZG; Dehkordi SN; Sohani SM; Yassin M
    Mult Scler Relat Disord; 2024 Jan; 81():105098. PubMed ID: 38000131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural adaptation and validation of the 12-item Multiple Sclerosis Walking Scale (MSWS-12) for the Brazilian population.
    Marangoni BE; Pavan K; Tilbery CP
    Arq Neuropsiquiatr; 2012 Dec; 70(12):922-8. PubMed ID: 23295419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric Properties of the HADS Measure of Anxiety and Depression Among Multiple Sclerosis Patients in Croatia.
    Jerković A; Proroković A; Matijaca M; Vuko J; Poljičanin A; Mastelić A; Ćurković Katić A; Košta V; Kustura L; Dolić K; Ðogaš Z; Rogić Vidaković M
    Front Psychol; 2021; 12():794353. PubMed ID: 34917005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the fatigue severity scale in Croatian population of patients with multiple sclerosis disease: Factor structure, internal consistency, and correlates.
    Jerković A; Proroković A; Matijaca M; Katić AĆ; Košta V; Mihalj M; Dolić K; Đogaš Z; Vidaković MR
    Mult Scler Relat Disord; 2022 Feb; 58():103397. PubMed ID: 35216780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and reliability of the Persian version of Recce stigma scale in people with multiple sclerosis and its impact on quality of life.
    Habibi MA; Yazdan Panah M; Vaheb S; Olfatifar M; Shaygannejad A; Mokary Y; Ghasemi M; Thapa S; Shaygannejad V; Mirmosayyeb O
    BMC Neurol; 2024 Jan; 24(1):36. PubMed ID: 38254066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis.
    Seebacher B; Mills RJ; Reindl M; Zamarian L; Kircher S; Brenneis C; Ehling R; Deisenhammer F
    BMC Neurol; 2021 Apr; 21(1):163. PubMed ID: 33865337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder.
    Kim W; Park EY; Hyun JW; Huh SY; Park NY; Jang H; Kim SH; Kim HJ
    J Clin Neurol; 2020 Apr; 16(2):270-276. PubMed ID: 32319244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory.
    Mokkink LB; Galindo-Garre F; Uitdehaag BM
    Mult Scler; 2016 Dec; 22(14):1867-1873. PubMed ID: 26873891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the Persian version of Depression Anxiety Stress Scale-21 Items (DASS-21) in a sample of health professionals: a cross-sectional study.
    Kakemam E; Navvabi E; Albelbeisi AH; Saeedikia F; Rouhi A; Majidi S
    BMC Health Serv Res; 2022 Jan; 22(1):111. PubMed ID: 35078477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
    Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ
    Neurology; 2003 Jan; 60(1):31-6. PubMed ID: 12525714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving our understanding of the most important items of the Multiple Sclerosis Walking Scale-12 indicating mobility dysfunction: Secondary results from a RIMS multicenter study.
    Kalron A; Ehling R; Baert I; Smedal T; Rasova K; Heric-Mansrud A; Elorriage I; Nedeljkovic U; Tachino A; Gargul L; Gusowski K; Cattaneo D; Borgers S; Hebert J; Dalgas U; Feys P
    Mult Scler Relat Disord; 2020 Nov; 46():102511. PubMed ID: 32949848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study.
    Baert I; Freeman J; Smedal T; Dalgas U; Romberg A; Kalron A; Conyers H; Elorriaga I; Gebara B; Gumse J; Heric A; Jensen E; Jones K; Knuts K; Maertens de Noordhout B; Martic A; Normann B; Eijnde BO; Rasova K; Santoyo Medina C; Truyens V; Wens I; Feys P
    Neurorehabil Neural Repair; 2014 Sep; 28(7):621-31. PubMed ID: 24503204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12).
    Motl RW; Snook EM
    J Neurol Sci; 2008 May; 268(1-2):69-73. PubMed ID: 18061618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.